Corpus Intelligence IC Memo — CHARLES A. CANNON MEMORIAL HOSPITAL 2026-04-26 15:42 UTC
IC Memo — CHARLES A. CANNON MEMORIAL HOSPITAL
Investment Committee Memorandum | NC | 23 beds | Grade C | EBITDA uplift $1.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CHARLES A. CANNON MEMORIAL HOSPITAL

CCN 341323 | AVERY, NC | 23 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CHARLES A. CANNON MEMORIAL HOSPITAL is a 23-bed rural/critical access in AVERY, NC with $20.2M in net patient revenue and a -22.6% operating margin. The hospital serves a payer mix of 54.7% Medicare, 2.6% Medicaid, and 42.7% commercial.

Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -22.6% to -15.2% (+736bps).

Net Revenue HCRIS$20.2M
Current EBITDA COMPUTED$-4.6M
Operating Margin COMPUTED-22.6%
Occupancy HCRIS17.1%
Revenue / Bed COMPUTED$878K
Net-to-Gross HCRIS36.6%
Distress Probability ML57.4%

2. Market Context & Competitive Position

129
NC Hospitals
-2.0%
State Median Margin
36
Comparable Hospitals

NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of -22.6% places it below the state median. Among 36 size-comparable peers (12-46 beds), the median margin is -5.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-46), prioritizing same-state peers. 36 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CHARLES A. CANNON MEMORIAL HOS (Target)NC23$20.2M-22.6%
DAVIE MEDICAL CENTERNC42$108.5M27.5%
NOVANT HEALTH MINT HILL MEDICANC36$107.8M9.7%
THE OUTER BANKS HOSPITALNC21$93.7M26.2%
MEDICAL PARK HOSPITALNC22$82.6M15.8%
GRANVILLE MEDICAL CENTERNC42$81.5M-5.4%
NORTH CAROLINA SPECIALTY HOSPINC18$71.6M11.7%
CAPE FEAR VALLEY HOKE HOSPITALNC41$71.5M19.3%
THE MCDOWELL HOSPITALNC30$65.7M-6.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$424K+210bp18mo
Cost to Collect4.5%2.5%$404K+200bp12mo
Denial Rate Reduction12.0%6.5%$400K+198bp12mo
A/R Days Reduction5200.0%3800.0%$246K+122bp9mo
Clean Claim Rate88.0%96.0%$13K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$424K
Cost to Collect
$404K
Denial Rate Reduction
$400K
A/R Days Reduction
$246K
Clean Claim Rate
$13K
Total EBITDA Uplift$1.5M
Current EBITDA$-4.6M
+ RCM Uplift+$1.5M
Pro Forma EBITDA$-3.1M
Current Margin-22.6%
Pro Forma Margin-15.2%
WC Released (1x)$775K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-7.0M$-15.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-7.0M$-19.1M0.00x-100.0%
Bull Case9.0x11.0x$-6.3M$-16.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-6.3M$-19.8M0.00x-100.0%
Bear Case11.0x10.0x$-7.7M$-20.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-7.7M$-25.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 17.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 36 hospitals with 12-46 beds
  • Same-state prioritization (n=37)
  • Comp margins: P25=-22.8% / P50=-5.4% / P75=4.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.